| Name | Sibrotuzumab |
|---|
| Description | Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targets fibroblast activation protein (FAP). Sibrotuzumab can be used for the research of colorectal cancer and non-small cell lung cancer (NSCLC)[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |